Malignant peritoneal mesothelioma in a child: chemotherapy with gemcitabine and platinum was effective for the disease unresponsive to other treatments

Anticancer Drugs. 2014 Oct;25(9):1102-5. doi: 10.1097/CAD.0000000000000143.

Abstract

Malignant peritoneal mesothelioma in children is a very rare disease and has a poor prognosis. Unlike malignant mesothelioma in adults, there is no clear causal association between this very rare malignancy in children and asbestos exposure. We report a case of peritoneal mesothelioma in an 11-year-old boy who presented with ascites. He was diagnosed with malignant mesothelioma on the basis of histopathological findings. His disease showed resistance to pemetrexed, but was treated successfully with platinum-based therapy with gemcitabine. He has achieved long-term survival in partial remission with stable disease.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Ascites / drug therapy
  • Child
  • Cisplatin / administration & dosage
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Drug Resistance, Neoplasm
  • Gemcitabine
  • Glutamates / therapeutic use
  • Guanine / analogs & derivatives
  • Guanine / therapeutic use
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Mesothelioma / drug therapy*
  • Mesothelioma, Malignant
  • Pemetrexed
  • Peritoneal Neoplasms / drug therapy*

Substances

  • Glutamates
  • Pemetrexed
  • Deoxycytidine
  • Guanine
  • Cisplatin
  • Gemcitabine